Steve has more than 25 years of experience in biotechnology and pharmaceutical development, including more than 13 years of experience working within the US Government as the Branch Chief, Antivirals and Antitoxins, CBRN Division, BARDA-ASPR, HHS.
Mr. Morris has a deep familiarity with the drug development lifecycle from discovery through preclinical and clinical development and licensure or approval.
He has extensive knowledge of USG non-dilutive funding mechanisms, contract negotiation, and post-award contract administration and deliverables.
He most recently led a consulting team at the world’s fifth-largest accounting and consulting firm helping clients secure hundreds of millions of dollars in funding through BARDA contracts and other Federal Awards.
Prior to consulting, he had a Senior leadership role at a vaccine development company.
